These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 1700210)

  • 1. Rate-dependent class III antiarrhythmic action, negative chronotropy, and positive inotropy of a novel Ik blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium.
    Tande PM; Bjørnstad H; Yang T; Refsum H
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):401-10. PubMed ID: 1700210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electromechanical action of dofetilide and D-sotalol during simulated metabolic acidosis in isolated guinea pig ventricular muscle.
    Yang T; Tande PM; Refsum H
    J Cardiovasc Pharmacol; 1992 Dec; 20(6):889-94. PubMed ID: 1282590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential rate and potassium-dependent effects of the class III agents d-sotalol and dofetilide on guinea pig papillary muscle.
    Marschang H; Beyer T; Karolyi L; Kübler W; Brachmann J
    Cardiovasc Drugs Ther; 1998 Dec; 12(6):573-83. PubMed ID: 10410827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiological effects of EGIS-7229, a new antiarrhythmic agent, in isolated mammalian and human cardiac tissues.
    Pankucsi C; Bányász T; Magyar J; Gyönös I; Kovács A; Varró A; Szénási G; Nánási PP
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):398-405. PubMed ID: 9089672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Negative chronotropic effect of a novel class III antiarrhythmic drug, UK-68,798, devoid of beta-blocking action on isolated guinea-pig atria.
    Yang T; Tande PM; Refsum H
    Br J Pharmacol; 1991 Jun; 103(2):1417-20. PubMed ID: 1679359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCB-328: a novel class III antiarrhythmic agent with little reverse frequency dependence in isolated guinea pig myocardium.
    Lee K; Lee JY; Kim HY; Kwon LS; Shin HS; Tanabe S; Kozono T; Park SD; Chung YS
    J Cardiovasc Pharmacol; 1998 Apr; 31(4):609-17. PubMed ID: 9554812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UK-68,798: a novel, potent and highly selective class III antiarrhythmic agent which blocks potassium channels in cardiac cells.
    Gwilt M; Arrowsmith JE; Blackburn KJ; Burges RA; Cross PE; Dalrymple HW; Higgins AJ
    J Pharmacol Exp Ther; 1991 Jan; 256(1):318-24. PubMed ID: 1988662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential class III and glibenclamide effects on action potential duration in guinea-pig papillary muscle during normoxia and hypoxia/ischaemia.
    MacKenzie I; Saville VL; Waterfall JF
    Br J Pharmacol; 1993 Oct; 110(2):531-8. PubMed ID: 8242227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cellular electrophysiological effects of a novel antiarrhythmic furoquinoline derivative HA-7 [N-benzyl-7-methoxy-2,3,4,9-tetrahydrofuro[2,3-b]quinoline-3,4-dione] in guinea pig cardiac preparations.
    Chang GJ; Su MJ; Kuo SC; Lin TP; Lee YS
    J Pharmacol Exp Ther; 2006 Jan; 316(1):380-91. PubMed ID: 16174797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes.
    Nakaya H; Tohse N; Takeda Y; Kanno M
    Br J Pharmacol; 1993 May; 109(1):157-63. PubMed ID: 7684298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electromechanical effects of zatebradine on isolated guinea pig cardiac preparations.
    Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):46-54. PubMed ID: 7564364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.
    Mori K; Hara Y; Saito T; Masuda Y; Nakaya H
    Circulation; 1995 Jun; 91(11):2834-43. PubMed ID: 7758191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class III antiarrhythmic action linked with positive inotropy: effects of the d- and l-isomer of sotalol on isolated rat atria at threshold and suprathreshold stimulation.
    Tande PM; Refsum H
    Pharmacol Toxicol; 1988 May; 62(5):272-7. PubMed ID: 3413029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-adrenoceptor activation plays a role in the reverse rate-dependency of effective refractory period lengthening by dofetilide in the guinea-pig atrium, in vitro.
    Kovács A; Magyar J; Bányász T; Nánási PP; Szénási G
    Br J Pharmacol; 2003 Aug; 139(8):1555-63. PubMed ID: 12922944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrophysiological and inotropic effects of H 234/09 (almokalant) in vitro: a comparison with two other novel IK blocking drugs, UK-68,798 (dofetilide) and E-4031.
    Abrahamsson C; Duker G; Lundberg C; Carlsson L
    Cardiovasc Res; 1993 May; 27(5):861-7. PubMed ID: 8348585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the two enantiomers, S-16257-2 and S-16260-2, of a new bradycardic agent on guinea-pig isolated cardiac preparations.
    Pérez O; Gay P; Franqueza L; Carrón R; Valenzuela C; Delpón E; Tamargo J
    Br J Pharmacol; 1995 Jul; 115(5):787-94. PubMed ID: 8548178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters.
    Wettwer E; Scholtysik G; Schaad A; Himmel H; Ravens U
    J Cardiovasc Pharmacol; 1991 Mar; 17(3):480-7. PubMed ID: 1711611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of KCB-328 and its analogues: novel class III antiarrhythmic agents with little reverse frequency dependence.
    Kim DI; Kim HY; Kwon LS; Park SD; Jeon GH; Jung KY; Min JK; Nam WH; Lee K; Chung YS; Tanabe S; Kozono T
    Bioorg Med Chem Lett; 1999 Jan; 9(1):85-90. PubMed ID: 9990462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sematilide, a novel class III antiarrhythmic agent, on action potential in guinea pig atrium.
    Ishii Y; Muraki K; Kurihara A; Imaizumi Y; Watanabe M
    Jpn J Pharmacol; 1995 Jun; 68(2):175-82. PubMed ID: 7563974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiarrhythmic and electrophysiological effects of GYKI-16638, a novel N-(phenoxyalkyl)-N-phenylalkylamine, in rabbits.
    Baczkó I; El-Reyani NE; Farkas A; Virág L; Iost N; Leprán I; Mátyus P; Varró A; Papp JG
    Eur J Pharmacol; 2000 Sep; 404(1-2):181-90. PubMed ID: 10980278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.